LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Minsky, Bruce D"
  2. AU="Manzano, Joanna-Grace M"
  3. AU="Acín-Pérez, Rebeca"
  4. AU="Kamakura, Tsukasa"
  5. AU="Lee, Theodore K"
  6. AU="So, Marvin"

Suchergebnis

Treffer 1 - 10 von insgesamt 259

Suchoptionen

  1. Artikel ; Online: Emerging trends in the treatment of rectal cancer.

    Minsky, Bruce D

    Acta oncologica (Stockholm, Sweden)

    2019  Band 58, Heft 10, Seite(n) 1343–1351

    Abstract: The conventional treatment for cT3-T4 or node-positive clinically resectable rectal cancer is long course preoperative chemoradiation followed by surgery and postoperative adjuvant chemotherapy. Disadvantages of this approach include possible ... ...

    Abstract The conventional treatment for cT3-T4 or node-positive clinically resectable rectal cancer is long course preoperative chemoradiation followed by surgery and postoperative adjuvant chemotherapy. Disadvantages of this approach include possible overtreatment of patients, 6 weeks of daily radiation treatment, and undetected metastatic disease. There are a number of emerging trends which are changing this approach to treatment. Selected topics included in this manuscript include the selective use of pelvic radiation, the role of radiation for a positive radial margin, the interval between radiation and surgery, non-operative management, new chemoradiation regimens, short vs. long course radiation, and the role of postoperative adjuvant chemotherapy.
    Mesh-Begriff(e) Chemoradiotherapy/methods ; Chemotherapy, Adjuvant/methods ; Clinical Trials, Phase III as Topic ; Disease-Free Survival ; Humans ; Neoadjuvant Therapy/methods ; Neoplasm Staging ; Patient Selection ; Proctectomy ; Radiotherapy Dosage ; Rectal Neoplasms/mortality ; Rectal Neoplasms/pathology ; Rectal Neoplasms/therapy ; Time Factors
    Sprache Englisch
    Erscheinungsdatum 2019-07-04
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ZDB-ID 896449-x
    ISSN 1651-226X ; 0349-652X ; 0284-186X ; 1100-1704
    ISSN (online) 1651-226X
    ISSN 0349-652X ; 0284-186X ; 1100-1704
    DOI 10.1080/0284186X.2019.1629009
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel: Neoadjuvant Treatment Strategies: Advanced Radiation Alternatives.

    Minsky, Bruce D

    Clinics in colon and rectal surgery

    2017  Band 30, Heft 5, Seite(n) 377–382

    Abstract: Long-course chemoradiation therapy (CRT) has been the standard approach for locally advanced rectal tumors. Neoadjuvant CRT is associated to improved local disease control, with less toxicity when compared with adjuvant CRT, as well as the chance for ... ...

    Abstract Long-course chemoradiation therapy (CRT) has been the standard approach for locally advanced rectal tumors. Neoadjuvant CRT is associated to improved local disease control, with less toxicity when compared with adjuvant CRT, as well as the chance for pathologic complete response. The CRT regimens have improved over the past years. This article will examine selected controversies, including novel chemoradiation regimens, duration of radiation (short vs. long course), and radiation techniques such as intensity-modulated radiation therapy (IMRT).
    Sprache Englisch
    Erscheinungsdatum 2017-11-27
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2048635-2
    ISSN 1531-0043
    ISSN 1531-0043
    DOI 10.1055/s-0037-1606115
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: New Paradigms in Rectal Cancer Multidisciplinary Care: Special Issue Introduction.

    Ashman, Jonathan B / Ma, Brigette / Minsky, Bruce D

    Clinical colorectal cancer

    2022  Band 21, Heft 1, Seite(n) 1–2

    Mesh-Begriff(e) Humans ; Rectal Neoplasms/diagnosis ; Rectal Neoplasms/therapy ; Rectum
    Sprache Englisch
    Erscheinungsdatum 2022-01-31
    Erscheinungsland United States
    Dokumenttyp Editorial
    ZDB-ID 2112638-0
    ISSN 1938-0674 ; 1533-0028
    ISSN (online) 1938-0674
    ISSN 1533-0028
    DOI 10.1016/j.clcc.2022.01.010
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel: Neoadjuvant Treatment Strategies: Advanced Radiation Alternatives

    Minsky, Bruce D.

    Clinics in Colon and Rectal Surgery

    (New Horizons in Rectal Cancer Management)

    2017  Band 30, Heft 05, Seite(n) 377–382

    Abstract: Long-course chemoradiation therapy (CRT) has been the standard approach for locally advanced rectal tumors. Neoadjuvant CRT is associated to improved local disease control, with less toxicity when compared with adjuvant CRT, as well as the chance for ... ...

    Serientitel New Horizons in Rectal Cancer Management
    Abstract Long-course chemoradiation therapy (CRT) has been the standard approach for locally advanced rectal tumors. Neoadjuvant CRT is associated to improved local disease control, with less toxicity when compared with adjuvant CRT, as well as the chance for pathologic complete response. The CRT regimens have improved over the past years. This article will examine selected controversies, including novel chemoradiation regimens, duration of radiation (short vs. long course), and radiation techniques such as intensity-modulated radiation therapy (IMRT).
    Schlagwörter rectal cancer ; chemoradiation therapy ; short course ; long course ; IMRT
    Sprache Englisch
    Erscheinungsdatum 2017-11-01
    Verlag Thieme Medical Publishers
    Erscheinungsort Stuttgart ; New York
    Dokumenttyp Artikel
    ZDB-ID 2072321-0
    ISSN 1530-9681 ; 1531-0043
    ISSN (online) 1530-9681
    ISSN 1531-0043
    DOI 10.1055/s-0037-1606115
    Datenquelle Thieme Verlag

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Future of therapy for rectal cancer.

    Minsky, Bruce D

    Chinese clinical oncology

    2013  Band 2, Heft 2, Seite(n) 19

    Abstract: Since 2004, the standard of care for patients with cT3 and/or N+ rectal cancer has been preoperative chemoradiation followed by surgery and postoperative adjuvant chemotherapy. A number of advances have occurred and are defining the future of rectal ... ...

    Abstract Since 2004, the standard of care for patients with cT3 and/or N+ rectal cancer has been preoperative chemoradiation followed by surgery and postoperative adjuvant chemotherapy. A number of advances have occurred and are defining the future of rectal cancer therapy. Among these are short course radiation, the impact of postoperative adjuvant chemotherapy, selective radiation and selective surgery, and new chemoradiation regimens with novel agents. This review will examine these developments and assess their impact on the future therapy of rectal cancer.
    Sprache Englisch
    Erscheinungsdatum 2013-06
    Erscheinungsland China
    Dokumenttyp Journal Article
    ZDB-ID 2828547-5
    ISSN 2304-3873 ; 2304-3865
    ISSN (online) 2304-3873
    ISSN 2304-3865
    DOI 10.3978/j.issn.2304-3865.2013.03.01
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Rectal cancer: is 'watch and wait' a safe option for rectal cancer?

    Minsky, Bruce D

    Nature reviews. Gastroenterology & hepatology

    2013  Band 10, Heft 12, Seite(n) 698–700

    Mesh-Begriff(e) Humans ; Rectal Neoplasms
    Sprache Englisch
    Erscheinungsdatum 2013-10-22
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2493722-8
    ISSN 1759-5053 ; 1759-5045
    ISSN (online) 1759-5053
    ISSN 1759-5045
    DOI 10.1038/nrgastro.2013.201
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Short-course radiation versus long-course chemoradiation for rectal cancer: making progress.

    Minsky, Bruce D

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    2012  Band 30, Heft 31, Seite(n) 3777–3778

    Mesh-Begriff(e) Adenocarcinoma/drug therapy ; Adenocarcinoma/radiotherapy ; Female ; Humans ; Male ; Neoplasm Recurrence, Local/pathology ; Rectal Neoplasms/drug therapy ; Rectal Neoplasms/radiotherapy
    Sprache Englisch
    Erscheinungsdatum 2012-11-01
    Erscheinungsland United States
    Dokumenttyp Comment ; Editorial
    ZDB-ID 604914-x
    ISSN 1527-7755 ; 0732-183X
    ISSN (online) 1527-7755
    ISSN 0732-183X
    DOI 10.1200/JCO.2012.45.0551
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel: Long-Term Patient-Reported Dyspareunia After Definitive Chemoradiation for Anal Cancer: Using the Anterior Vaginal Wall as an Organ-at-Risk to Define an Actionable Dosimetric Goal.

    Rooney, Michael K / Niedzielski, Joshua S / Salazar, Ramon M / Arzola, Angelica / Das, Prajnan / Koay, Eugene J / Koong, Albert / Ludmir, Ethan B / Minsky, Bruce D / Noticewala, Sonal / Smith, Grace L / Taniguchi, Cullen / Holliday, Emma B

    Advances in radiation oncology

    2024  Band 9, Heft 5, Seite(n) 101449

    Abstract: Purpose: Chemoradiation therapy (CRT) is the standard treatment for squamous cell carcinoma of the anus (SCCA). This study aimed to investigate the relationship between vaginal dosimetry and long-term patient-reported dyspareunia after treatment. We ... ...

    Abstract Purpose: Chemoradiation therapy (CRT) is the standard treatment for squamous cell carcinoma of the anus (SCCA). This study aimed to investigate the relationship between vaginal dosimetry and long-term patient-reported dyspareunia after treatment. We further aimed to use the anterior vaginal wall (AVW) as an organ at risk to define an actionable dosimetric clinical goal to decrease the risk of patient-reported dyspareunia.
    Methods and materials: Women with SCCA treated with intensity modulated radiation therapy-based CRT were surveyed at least 2 years after successfully completing therapy. A Female Sexual Function Index (FSFI) pain subscore ≤4 was used to define dyspareunia. Dosimetric parameters were calculated for both the full vaginal canal and AVW. Multivariable linear regression models were created to identify predictors of FSFI pain subscore using backward selection to identify final variables include in the models. An actionable dosimetric predictor for dyspareunia was established using the Youden index method for cutoff optimization.
    Results: Of 184 women who were contacted, 90 (49%) returned completed surveys. Of those who completed surveys, 51 (56.7%) reported being sexually active, and 47 had dosimetric data available for review. Of sexually active respondents, 32 (68%) had an FSFI pain subscore ≤4. Multiple regression models were generated using the full vaginal canal and AVW as organs at risk, and both models showed similar predictive relationships with volumetric dose parameters emerging as the best dosimetric predictors for dysparenuia. Age over 65 years was also associated with higher FSFI pain subscores (eg, less pain with intercourse) in both models. AVW V35 Gy < 60% was identified as the optimal cutoff to reduce the risk of patient-reported dyspareunia.
    Conclusions: Increased dose to the vaginal canal is significantly associated with worse patient-reported dyspareunia following CRT for SCCA. Minimizing dose to the AVW to V35 Gy < 60% may reduce the risk of this quality of life-limiting toxicity. Further prospective evaluation is needed to validate these findings.
    Sprache Englisch
    Erscheinungsdatum 2024-02-02
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ISSN 2452-1094
    ISSN 2452-1094
    DOI 10.1016/j.adro.2024.101449
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Unique considerations in the patient with rectal cancer.

    Minsky, Bruce D

    Seminars in oncology

    2011  Band 38, Heft 4, Seite(n) 542–551

    Abstract: In the past two decades, substantial progress has been made in the adjuvant management of colorectal cancer. Chemotherapy has improved overall survival in patients with node-positive (N+) disease. In contrast with colon cancer, which has a low incidence ... ...

    Abstract In the past two decades, substantial progress has been made in the adjuvant management of colorectal cancer. Chemotherapy has improved overall survival in patients with node-positive (N+) disease. In contrast with colon cancer, which has a low incidence of local recurrence, patients with rectal cancer have a higher incidence requiring the addition of pelvic radiation therapy (chemoradiation). Patients with rectal cancer have a number of unique management considerations: for example, the role of short-course radiation, whether postoperative adjuvant chemotherapy is necessary for all patients, and if the type of surgery following chemoradiation should be based on the response rate. More accurate imaging techniques and/or molecular markers may help identify patients with positive pelvic nodes to reduce the chance of overtreatment with preoperative therapy. Will more effective systemic agents both improve the results of radiation as well as modify the need for pelvic radiation? This review will address these and other controversies specific to patients with rectal cancer.
    Mesh-Begriff(e) Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Carcinoma/therapy ; Combined Modality Therapy/methods ; Combined Modality Therapy/trends ; Dissent and Disputes ; Humans ; Postoperative Period ; Preoperative Period ; Radiotherapy, Adjuvant/methods ; Rectal Neoplasms/therapy
    Sprache Englisch
    Erscheinungsdatum 2011-08
    Erscheinungsland United States
    Dokumenttyp Evaluation Studies ; Journal Article ; Review
    ZDB-ID 189220-4
    ISSN 1532-8708 ; 0093-7754
    ISSN (online) 1532-8708
    ISSN 0093-7754
    DOI 10.1053/j.seminoncol.2011.05.008
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Progress in the treatment of locally advanced clinically resectable rectal cancer.

    Minsky, Bruce D

    Clinical colorectal cancer

    2011  Band 10, Heft 4, Seite(n) 227–237

    Abstract: There have been significant developments in the adjuvant treatment of locally advanced clinically resectable (T3 and/or N+) rectal cancer. Postoperative systemic chemotherapy plus concurrent pelvic irradiation (chemoradiation) significantly improves ... ...

    Abstract There have been significant developments in the adjuvant treatment of locally advanced clinically resectable (T3 and/or N+) rectal cancer. Postoperative systemic chemotherapy plus concurrent pelvic irradiation (chemoradiation) significantly improves local control and survival compared with surgery alone. The German Rectal Cancer Trial confirmed that when chemoradiation is delivered preoperatively there is a significant decrease in acute and late toxicity and a corresponding increase in local control and sphincter preservation. Despite these advances, controversies remain. Among these controversies are the role of short-course radiation, whether postoperative adjuvant chemotherapy is necessary for all patients, and if the type of surgery after chemoradiation can be modified based on tumor response. Are there more accurate imaging techniques and/or molecular markers to help identify patients with positive pelvic nodes with the goal of reducing the chance of overtreatment with preoperative therapy. Will more effective systemic agents both improve outcome and modify the need for pelvic irradiation? This review examines the advances in chemoradiation as well as addresses these and other opportunities for improvement.
    Mesh-Begriff(e) Animals ; Combined Modality Therapy ; Humans ; Neoadjuvant Therapy ; Rectal Neoplasms/therapy ; Treatment Outcome
    Sprache Englisch
    Erscheinungsdatum 2011-12
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2112638-0
    ISSN 1938-0674 ; 1533-0028
    ISSN (online) 1938-0674
    ISSN 1533-0028
    DOI 10.1016/j.clcc.2011.06.007
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang